High-throughput matrix screening reveals synergistic chemotherapeutic combinations with blockade of CD47 to enhance cytotoxicity in breast cancer

被引：0
|
作者：
Roberts, David D.
Smith, Ashley
Sipes, John M.
Wilson, Adam
Mathews-Griner, Lesley
Guha, Rajarshi
Thomas, Craig J.
Ferrer, Marc
Soto-Pantoja, David R.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-1352
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1352
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Combined high expression of CD47 and CD68 is a novel prognostic factor for breast cancer patients
    Yuan, Jingping
    He, Huihua
    Chen, Chuang
    Wu, Juan
    Rao, Jie
    Yan, Honglin
    CANCER CELL INTERNATIONAL, 2019, 19 (01)
  • [22] Self-Promoted Targeting Delivery of Nanodrug Through Chemotherapeutic Upregulation of CD47 for Triple Negative Breast Cancer Therapy
    Liu, Qianqian
    Chen, Xiayun
    Jiang, Yong
    Yan, Mengyi
    Yu, Baixue
    Zhang, Wei
    Cen, Yi
    Zhang, Junyan
    Zhang, Jian
    Lei, Qi
    Li, Shiying
    Yang, Bin
    ADVANCED FUNCTIONAL MATERIALS, 2024, 34 (13)
  • [23] Correction: Corrigendum: High-throughput RNAi screen for essential genes and drug synergistic combinations in colorectal cancer
    Steven P. Williams
    Andrew S. Barthorpe
    Howard Lightfoot
    Mathew J. Garnett
    Ultan McDermott
    Scientific Data, 5
  • [24] Zebrafish xenograft breast cancer models for high-throughput drug response screening
    Schmitz, Rebecca
    Walsh, Alex J.
    Tweed, Kelsey
    Trier, Steve
    Huttenlocher, Anna
    Skala, Melissa C.
    BIOPHYSICS, BIOLOGY AND BIOPHOTONICS IV: THE CROSSROADS, 2019, 10888
  • [25] High-throughput screening for natural compound-based autophagy modulators reveals novel chemotherapeutic mode of action for arzanol
    Deitersen, Jana
    Berning, Lena
    Stuhldreier, Fabian
    Ceccacci, Sara
    Schluetermann, David
    Friedrich, Annabelle
    Wu, Wenxian
    Sun, Yadong
    Boehler, Philip
    Berleth, Niklas
    Mendiburo, Maria Jose
    Seggewiss, Sabine
    Anand, Ruchika
    Reichert, Andreas S.
    Monti, Maria Chiara
    Proksch, Peter
    Stork, Bjoern
    CELL DEATH & DISEASE, 2021, 12 (06)
  • [26] High-throughput screening for natural compound-based autophagy modulators reveals novel chemotherapeutic mode of action for arzanol
    Jana Deitersen
    Lena Berning
    Fabian Stuhldreier
    Sara Ceccacci
    David Schlütermann
    Annabelle Friedrich
    Wenxian Wu
    Yadong Sun
    Philip Böhler
    Niklas Berleth
    María José Mendiburo
    Sabine Seggewiß
    Ruchika Anand
    Andreas S. Reichert
    Maria Chiara Monti
    Peter Proksch
    Björn Stork
    Cell Death & Disease, 12
  • [27] High-throughput tissue microarray analysis reveals telomerase as prognostic marker in breast cancer
    Poremba, C
    Diallo, R
    Heine, B
    Heinecke, A
    Sauter, G
    Dockhorn-Dworniczak, B
    Boecker, W
    MODERN PATHOLOGY, 2002, 15 (01) : 47A - 47A
  • [28] High-throughput tissue microarray analysis reveals telomerase as prognostic marker in breast cancer
    Poremba, C
    Diallo, R
    Heine, B
    Heinecke, A
    Sauter, G
    Dockhorn-Dworniczak, B
    Boecker, W
    LABORATORY INVESTIGATION, 2002, 82 (01) : 47A - 47A
  • [29] High-throughput matrix screening in ovarian cancer cells identifies synergistic drug combinations with the second mitochondrial-derived activator of caspases (SMAC) mimetic birinapant (TL32711)
    Bunch, K. P.
    Goldlust, I. S.
    Thomas, C. J.
    Annunziata, C. M.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 207 - 208
  • [30] Combining CD47 blockade with trastuzumab eliminates HER2-positive breast cancer cells and overcomes trastuzumab tolerance
    Upton, Rosalynd
    Banuelos, Allison
    Feng, Dongdong
    Biswas, Tanuka
    Kao, Kevin
    McKenna, Kelly
    Willingham, Stephen
    Ho, Po Yi
    Rosental, Benyamin
    Tal, Michal Caspi
    Raveh, Tal
    Volkmer, Jens-Peter
    Pegram, Mark D.
    Weissman, Irving L.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (29)
12345